Daclatasvir Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with daclatasvir
A
- A-D Anti-Diarrheal (loperamide)
- abametapir topical
- abiraterone / niraparib
- Abraxane (paclitaxel protein-bound)
- abrocitinib
- acarbose
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir)
- AccessPak for HIV PEP Expanded with Viracept (emtricitabine / nelfinavir / tenofovir)
- Accretropin (somatropin)
- acetohexamide
- ActoPlus Met (metformin / pioglitazone)
- ActoPlus Met XR (metformin / pioglitazone)
- Actos (pioglitazone)
- adagrasib
- Adalat (nifedipine)
- Adalat CC (nifedipine)
- Adcetris (brentuximab)
- Addyi (flibanserin)
- Adlyxin (lixisenatide)
- Admelog (insulin lispro)
- Adrenocot (dexamethasone)
- Adrenocot LA (dexamethasone)
- Adriamycin (doxorubicin)
- Adriamycin PFS (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Advicor (lovastatin / niacin)
- afatinib
- Afeditab CR (nifedipine)
- Afinitor (everolimus)
- Afinitor Disperz (everolimus)
- Afrezza (insulin inhalation, rapid acting)
- Agenerase (amprenavir)
- Akeega (abiraterone / niraparib)
- Akynzeo (netupitant / palonosetron)
- Akynzeo for Injection (fosnetupitant / palonosetron)
- albiglutide
- aliskiren
- aliskiren / amlodipine
- aliskiren / amlodipine / hydrochlorothiazide
- aliskiren / hydrochlorothiazide
- aliskiren / valsartan
- Alkabel-SR (atropine / hyoscyamine / phenobarbital / scopolamine)
- Allegra (fexofenadine)
- Allegra Allergy (fexofenadine)
- Allegra Hives (fexofenadine)
- Allegra ODT (fexofenadine)
- Allegra-D 12 Hour (fexofenadine / pseudoephedrine)
- Allegra-D 12 Hour Allergy & Congestion (fexofenadine / pseudoephedrine)
- Allegra-D 24 Hour (fexofenadine / pseudoephedrine)
- Allegra-D 24 Hour Allergy & Congestion (fexofenadine / pseudoephedrine)
- Aller-Ease (fexofenadine)
- alogliptin
- alogliptin / metformin
- alogliptin / pioglitazone
- alpelisib
- Altocor (lovastatin)
- Altoprev (lovastatin)
- Alunbrig (brigatinib)
- Amaryl (glimepiride)
- ambrisentan
- aminophylline / ephedrine / guaifenesin / phenobarbital
- aminophylline / ephedrine / phenobarbital / potassium iodide
- amlodipine / atorvastatin
- amoxicillin / clarithromycin / lansoprazole
- amoxicillin / clarithromycin / omeprazole
- amoxicillin / clarithromycin / vonoprazan
- amoxicillin / omeprazole / rifabutin
- amprenavir
- Amturnide (aliskiren / amlodipine / hydrochlorothiazide)
- anisindione
- Anti-Diarrheal (loperamide)
- Anti-Diarrheal + Anti-Gas (loperamide / simethicone)
- Antispas (atropine / hyoscyamine / phenobarbital / scopolamine)
- Antispasmodic (atropine / hyoscyamine / phenobarbital / scopolamine)
- Antrocol (atropine / phenobarbital)
- apalutamide
- Apidra (insulin glulisine)
- Apidra SoloStar (insulin glulisine)
- apixaban
- Aponvie (aprepitant)
- aprepitant
- Aptivus (tipranavir)
- Arcapta (indacaterol)
- artesunate
- Arymo ER (morphine)
- asciminib
- aspirin / pravastatin
- Aspruzyo Sprinkle (ranolazine)
- Astramorph PF (morphine)
- atazanavir
- atazanavir / cobicistat
- atogepant
- Atorvaliq (atorvastatin)
- atorvastatin
- atorvastatin / ezetimibe
- Atripla (efavirenz / emtricitabine / tenofovir)
- atropine / hyoscyamine / phenobarbital / scopolamine
- atropine / phenobarbital
- Augtyro (repotrectinib)
- avacopan
- Avandamet (metformin / rosiglitazone)
- Avandaryl (glimepiride / rosiglitazone)
- Avandia (rosiglitazone)
- Avinza (morphine)
More about daclatasvir
- daclatasvir consumer information
- Check interactions
- Compare alternatives
- Reviews (10)
- Side effects
- Dosage information
- During pregnancy
- Drug class: NS5A inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.